Patents by Inventor Mary Jane Cardosa

Mary Jane Cardosa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Allergenic proteins of natural rubber latex, their production and use in assays
    Publication number: 20090285859
    Abstract: This invention relates to allergenic proteins of natural rubber latex in substantially purified form, their production and their use, together with monoclonal antibodies developed against those allergenic proteins, in assays for the qualitative and quantitative determination of the levels of the allergenic proteins in natural rubber latex or in products made from latex. Assays for identifying and/or quantitating antibodies in blood or blood products that mediate the occurrence of an allergic reaction induced by natural rubber latex are also provided, together with in vivo and in vitro diagnostic tests for detecting hypersensitivity to natural rubber latex and which involve use of the aforesaid allergenic proteins. The invention also provides for the use of the aforesaid allergens as de-sensitising agents in the treatment of latex protein allergy. There is still further provided a method for removing allergenic proteins from latex products.
    Type: Application
    Filed: July 15, 2009
    Publication date: November 19, 2009
    Inventors: Mary Jane Cardosa, Hamid Sharifah, Shirley Samuel-Verghese, Elumalai Sunderasan, Hoong Yeet Yeang, Hamzah Samsidar
  • Allergenic proteins of natural rubber latex, their production and use in assays
    Patent number: 7576184
    Abstract: This invention relates to allergenic proteins of natural rubber latex in substantially purified form, their production and their use, together with monoclonal antibodies developed against those allergenic proteins, in assays for the qualitative and quantitative determination of the levels of the allergenic proteins in natural rubber latex or in products made from latex. Assays for identifying and/or quantitating antibodies in blood or blood products that mediate the occurrence of an allergic reaction induced by natural rubber latex are also provided, together with in vivo and in vitro diagnostic tests for detecting hypersensitivity to natural rubber latex and which involve use of the aforesaid allergenic proteins. The invention also provides for the use of the aforesaid allergens as de-sensitising agents in the treatment of latex protein allergy. There is still further provided a method for removing allergenic proteins from latex products.
    Type: Grant
    Filed: April 8, 2004
    Date of Patent: August 18, 2009
    Assignees: The Board of the Rubber Research Institute of Malaysia, Universiti Sains Malaysia
    Inventors: Mary Jane Cardosa, Hamid Sharifah, Shirley Samuel-Verghese, Elumalai Sunderasan, Hoong Yeet Yeang, Hamzah Samsidar
  • Recombinant MVA virus expressing dengue virus antigens, and the use thereof in vaccines
    Patent number: 6869793
    Abstract: Recombinant MVA viruses containing and/or capable of expressing dengue virus antigens and the use of such recombinant MVA for vaccination.
    Type: Grant
    Filed: September 23, 1997
    Date of Patent: March 22, 2005
    Assignee: Bavarian Nordic Research Institute
    Inventors: Mary Jane Cardosa, Gerd Sutter, Volker Erfle
  • Recombinant MVA virus expressing dengue virus antigens, and the use thereof in vaccines
    Publication number: 20040265324
    Abstract: Recombinant MVA viruses containing and/or capable of expressing dengue virus antigens and the use of such recombinant MVA for vaccination.
    Type: Application
    Filed: February 24, 2004
    Publication date: December 30, 2004
    Inventors: Mary Jane Cardosa, Gerd Sutter, Volker Erfle
  • Allergenic proteins of natural rubber latex, their production and use in assays
    Patent number: 6759517
    Abstract: This invention relates to allergenic proteins of natural rubber latex in substantially purified form, their production and their use, together with monoclonal antibodies developed against those allergenic proteins, in assays for the qualitative and quantitative determination of the levels of the allergenic proteins in natural rubber latex or in products made from latex. Assays for identifying and/or quantitating antibodies in blood or blood products that mediate the occurrence of an allergic reaction induced by natural rubber latex are also provided, together with in vivo and in vitro diagnostic tests for detecting hypersensitivity to natural rubber latex and which involve use of the aforesaid allergenic proteins. The invention also provides for the use of the aforesaid allergens as de-sensitizing agents in the treatment of latex protein allergy. There is still further provided a method for removing allergenic proteins from latex products.
    Type: Grant
    Filed: September 15, 1995
    Date of Patent: July 6, 2004
    Assignees: Universiti Sains Malaysia, The Board of the Rubber Research Institute of Malaysia
    Inventors: Mary Jane Cardosa, Hamid Sharifah, Shirley Samuel-Verghese, Elumalai Sunderasan, Hoong Yeet Yeang, Hamzah Samsidar
  • RECOMBINANT MVA VIRUS EXPRESSING DENGUE VIRUS ANTIGENS, AND THE USE THEREOF IN VACCINES
    Publication number: 20030082205
    Abstract: Recombinant MVA viruses containing and/or capable of expressing dengue virus antigens and the use of such recombinant MVA for vaccination.
    Type: Application
    Filed: March 23, 1999
    Publication date: May 1, 2003
    Inventors: MARY JANE CARDOSA, GERD SUTTER, VOLKER ERFLE